Basics IGM Biosciences, Inc. IPO Date: September 16, 2019 Sector: Healthcare Industry: Biotech Market Cap: $73.34M Activated in VL: True Average Daily Range Avg Daily Range: $1.35 | 4.38% Avg Daily Range (30 D): $0.05 | 4.00% Avg Daily Range (90 D): $0.05 | 3.60% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .15M Avg Daily Volume (90 D): .2M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 161 Avg Trade Size (Sh.) (90 D): 148 Institutional Trades Total Inst.Trades: 719 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.06M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.87M Avg Closing Trade (30 D): $1.46M Avg Closing Trade (90 D): $1.46M Avg Closing Volume: 48.62K         News Jan 9, 2025 @ 6:00 PM IGM Biosciences Provides Strategic Update on Autoi... Source: N/A Nov 4, 2024 @ 12:00 PM IGM Biosciences to Present at Three Upcoming Inves... Source: N/A Sep 18, 2024 @ 3:22 PM Russell 2000 Outpaces S&P 500 As Small Caps Antici... Source: Surbhi Jain Jul 12, 2024 @ 8:25 PM Russell 2000 Index Notches Strongest Week Of Year,... Source: Piero Cingari, Benzinga Staff Writer May 29, 2024 @ 11:00 AM IGM Biosciences to Present at the Jefferies Health... Source: IGM Biosciences, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.27 $-.86 $-.61 Diluted EPS $-3.27 $-.86 $-.61 Revenue $ 2.68M $ .5M $ .41M Gross Profit $ $ $ Net Income / Loss $ -198.87M $ -52.89M $ -36.65M Operating Income / Loss $ -209.5M $ -54.78M $ -38.98M Cost of Revenue $ $ $ Net Cash Flow $ -42.61M $ 10.22M $ -16.4M PE Ratio